In this episode of NGBiLab, host Jim Wilson welcomes the innovative minds behind YellowBird Diagnostics: Nicholas Calvert, Alexia Kirby, and Adam Shuhendler. Discover how this dynamic team, spun out of the University of Ottawa, is revolutionizing disease diagnosis with cutting-edge chemical technologies. From their entrepreneurial journey to the challenges of bringing molecular imaging to the clinic, this conversation delves into the heart of innovation in the life sciences sector. Tune in to learn about their vision to become leaders in advanced imaging dye innovation and their plans for the future.

In this engaging episode, Jim Wilson sits down with Marc Jeschke, a renowned surgeon and researcher, to explore his fascinating journey from Germany to becoming a leading figure in burn care and research. Marc shares insights into his early life, the challenges and triumphs of his career, and his vision for the future of healthcare. Discover how his passion for innovation and dedication to patient care have shaped his path and continue to drive his work at Hamilton Health Sciences.

In this archived episode of NGBiLab, host Jim Wilson revisits his conversation with Bronwyn Bridges, CEO and co-founder of PragmaClin, a pioneering startup from St. John's, Newfoundland. PragmaClin's innovative digital tool, Prims, is designed to enhance the assessment of Parkinson's disease, offering more objective and efficient pathways for neurological care. Bronwyn reflects on her journey, the hurdles overcome, and the serendipitous moments that shaped PragmaClin's mission to make healthcare more accessible.

In this archive episode of NGBideas, host Jim Wilson sits down with Professor Christine Allen from the University of Toronto's Leslie Dan Faculty of Pharmacy. Join us as we explore Dr. Allen's remarkable journey from her early days in Ottawa to becoming a globally recognized leader in drug formulation and development. Discover her insights on the integration of AI in drug development, her experiences in academia and industry, and her inspiring personal story of resilience and innovation. Tune in for an engaging conversation that delves into the future of life sciences and the power of formulation to transform medicine.

In this throwback episode of NGBiLab, host Jim Wilson sits down with Kevin Neal and Jean-Francois Mio from Tatum Bioscience in Sherbrooke, Quebec. Discover how they are revolutionizing cancer treatment by programming bacteria to become cancer-fighting drugs. Learn about their journey, the challenges they face, and their vision for the future of immunotherapy. Tune in to explore the cutting-edge innovations in Canada's life sciences sector.

In this throwback episode of NGBideas, host Jim Wilson sits down with Brigitte Nolet, President and CEO of Roche Canada Pharma. They explore Brigitte's journey as a trisector leader, her personal experiences as a patient, and her insights into Canada's life sciences sector. Discover the importance of honesty in leadership and the potential of healthcare innovation. Tune in for an inspiring conversation about resilience, ambition, and the future of healthcare in Canada.

This week, we’re throwing it back to when Jim connected with Sydney Robinson, CEO and co-founder of Vessl Prosthetics, based in London, Ontario. Sydney and her team are pioneering next-generation prosthetic solutions specifically designed for below-knee amputees. Their innovative technology features automatic adjustments that ensure a consistently comfortable fit—greatly improving quality of life for many.

In 2025, Vessl Prosthetics made significant strides, securing key funding and expanding their impact in the prosthetics field. Their journey perfectly exemplifies the spirit of innovation and collaboration that NGBi is proud to amplify—showcasing real-world breakthroughs happening across Canada’s life sciences ecosystem.

Tune in to hear their inspiring story, and stay connected for more fresh conversations coming soon!

This week, we’re revisiting an episode with Cate Murray, President and CEO of the Stem Cell Network (SCN) in Ottawa. SCN is a Canadian not-for-profit supporting three main objectives: advancing stem cell and regenerative medicine research, training the next generation of researchers, and sharing breakthroughs in this incredible field.Founded in 2001 with federal support, SCN has grown from a few dozen labs to over 270 world-class research groups and dozens of clinical trials.

Cate will also be joining NGBi25 to speak about regenerative medicine, sharing her insights on the latest innovations and trends in this exciting field.